Alzheimer’s drugs slammed as ‘ineffective’ in major review, but critics push back
A major Cochrane review recently cast doubt on the safety and effectiveness of amyloid-targeting Alzheimer’s drugs, although some experts and drugmakers have disputed the researchers' conclusions.These types of monoclonal antibodies are designed to reduce or remove amyloid-beta, a naturally occurring protein that can accumulate into sticky plaques in the brains of people with Alzheimer’s disease.In the review, researchers analyzed results from 17 clinical trials involving 20,342 participants who had mild […]
